IR@PKUHSC  > 北京大学基础医学院
学科主题基础医学
Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation
Dong, Shuying1; Kong, Jian1; Kong, Fandong5,6; Kong, Jinge5,6; Gao, Jun1; Ji, Liang2,3,4; Pan, Bing2,3,4; Chen, Lian7; Zheng, Lemin2,3,4; Sun, Wenbing1
关键词Hepatocellular carcinoma Insufficient radiofrequency ablation Epithelial-mesenchymal transition Sorafenib
刊名BMC CANCER
2015-11-30
DOI10.1186/s12885-015-1949-7
15
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]RAPID PROGRESSION ; PATHWAYS ; CHEMOEMBOLIZATION ; METASTASIS ; INHIBITION ; THERAPY ; CANCER
英文摘要

Background: Epithelial-mesenchymal transition (EMT) played an important role in the progression of hepatocellular carcinoma (HCC) after insufficient radiofrequency ablation (RFA). However, whether sorafenib could be used to suppress the EMT of HCC after insufficient RFA and further prevent the progression of residual HCC remains poorly unknown.

Methods: Insufficient RFA was simulated using a water bath (47 degrees C 5, 10, 15, 20 and 25 min gradually). MTT assay and transwell assay were used to evaluate the effects of sorafenib on viability, migration and invasion of HepG2 and SMMC7721 cells after insufficient RFA in vitro. After insufficient RFA, the molecular changes in HCC cells with the treatment of sorafeinb were evaluated using western blot and ELISAs. An ectopic nude mice model was used to evaluate the effect of sorafenib on the growth of HepG2 cells in vivo after insufficient RFA.

Results: HepG2 and SMMC7721 cells after insufficient RFA (named as HepG2-H and SMMC7721-H) exhibited enhanced viability, migration and invasion in vitro. Sorafenib inhibited the enhanced viability, migration and invasion of HepG2 and SMMC7721 cells after insufficient RFA. Molecular changes of EMT were observed in HepG2-H and SMMC7721-H cells. Sorafenib inhibited the EMT of HepG2-H and SMMC7721-H cells. HepG2-H cells also exhibited larger tumor size in vivo. Higher expression of PCNA, Ki67, N-cadherin, MMP-2 and MMP-9, was also observed in HepG2-H tumors. Sorafenib blocked the enhanced growth of HepG2 cells in vivo after insufficient RFA.

Conclusions: Sorafenib inhibited the EMT of HCC cells after insufficient RFA, and may be used to prevent the progression of HCC after RFA.

语种英语
WOS记录号WOS:000365490400001
项目编号320675007131 ; 32067501207 ; 2011CB503900 ; 81170101 ; 81370235 ; 81572957 ; 81502650 ; 7122106
资助机构Dr. Jieping Wu Medical Foundation ; Program for Medical Key Discipline of Shijingshan District, Beijing ; "973" National ST Major Project ; National Natural Science Foundation of China ; Natural Science Foundation of Beijing, China
引用统计
被引频次:7[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/63140
专题北京大学基础医学院
作者单位1.Capital Med Univ, Beijing Chao Yang Hosp, Dept Hepatobiliary Surg, Beijing 100043, Peoples R China
2.Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Beijing 100191, Peoples R China
3.Peking Univ, Hlth Sci Ctr, Key Lab Mol Cardiovasc Sci, Minist Educ,Inst Cardiovasc Sci, Beijing 100191, Peoples R China
4.Peking Univ, Hlth Sci Ctr, Inst Syst Biomed, Beijing 100191, Peoples R China
5.Peking Univ, Neurosci Res Inst, Sch Basic Med Sci, Dept Neurobiol, Beijing 100191, Peoples R China
6.Peking Univ, Natl Hlth & Family Planning Commiss, Minist Educ, Key Lab Neurosci, Beijing 100191, Peoples R China
7.Fujian Med Univ, Affiliated Mindong Hosp, Dept Orthopaed 8, Fuzhou 355000, Fujian, Peoples R China
推荐引用方式
GB/T 7714
Dong, Shuying,Kong, Jian,Kong, Fandong,et al. Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation[J]. BMC CANCER,2015,15.
APA Dong, Shuying.,Kong, Jian.,Kong, Fandong.,Kong, Jinge.,Gao, Jun.,...&Sun, Wenbing.(2015).Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.BMC CANCER,15.
MLA Dong, Shuying,et al."Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation".BMC CANCER 15(2015).
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
Sorafenib suppresses(5368KB)期刊论文出版稿开放获取CC BY-NC-SA浏览 请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Dong, Shuying]的文章
[Kong, Jian]的文章
[Kong, Fandong]的文章
百度学术
百度学术中相似的文章
[Dong, Shuying]的文章
[Kong, Jian]的文章
[Kong, Fandong]的文章
必应学术
必应学术中相似的文章
[Dong, Shuying]的文章
[Kong, Jian]的文章
[Kong, Fandong]的文章
相关权益政策
暂无数据
收藏/分享
文件名: Sorafenib suppresses the epithelial-mesenchymal transition of hepatocellular carcinoma cells after insufficient radiofrequency ablation.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。